Top Markets
#1 Siren Siren +38.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.79%
#3 RedStone RedStone +18.90%
#4 Verus Coin Verus Coin +18.06%
#5 Ocean Protocol Ocean Protocol +15.61%
#6 Cysic Cysic +15.47%
#7 OpenEden OpenEden +14.56%
#8 Perle Perle +12.68%
#9 KUB Coin KUB Coin +12.53%
#10 Arowana Arowana +11.84%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rang in Aktien #32153
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Aktienkurs
$0.05504527
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$10.89M
Veränderung (1 Tag)
15.38%
Veränderung (1 Jahr)
-10.64%
Land
CA
Handel Hemostemix Inc. (HEM)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Hemostemix Inc. (HEM)
Dividendenrendite (TTM) von Hemostemix Inc. (Aktienkürzel: HEM) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Hemostemix Inc. (HEM) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR